Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants.

PubWeight™: 2.62‹?› | Rank: Top 1%

🔗 View Article (PMC 96380)

Published in Infect Immun on February 01, 1999

Authors

P C Bull1, B S Lowe, M Kortok, K Marsh

Author Affiliations

1: Kenya Medical Research Institute CGMRC, Kilifi Unit, Kilifi, Kenya. pbull@africaonline.co

Articles citing this

Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J Exp Med (2004) 3.63

Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions. Malar J (2003) 3.57

Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J Infect Dis (1999) 3.56

Patterns of gene recombination shape var gene repertoires in Plasmodium falciparum: comparisons of geographically diverse isolates. BMC Genomics (2007) 2.23

Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria. Proc Natl Acad Sci U S A (2000) 2.19

Differential expression of var gene groups is associated with morbidity caused by Plasmodium falciparum infection in Tanzanian children. Infect Immun (2006) 2.16

Plasmodium falciparum variant surface antigen expression patterns during malaria. PLoS Pathog (2005) 2.13

Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses. J Exp Med (1999) 2.11

Virulence in malaria: an evolutionary viewpoint. Philos Trans R Soc Lond B Biol Sci (2004) 2.04

Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. Infect Immun (2002) 2.00

A restricted subset of var genes mediates adherence of Plasmodium falciparum-infected erythrocytes to brain endothelial cells. Proc Natl Acad Sci U S A (2012) 1.90

Immunity promotes virulence evolution in a malaria model. PLoS Biol (2004) 1.69

Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome. PLoS One (2011) 1.62

Nine-year longitudinal study of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes. Infect Immun (1999) 1.59

Investigating the host binding signature on the Plasmodium falciparum PfEMP1 protein family. PLoS Pathog (2011) 1.53

An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype. Infect Immun (2008) 1.45

Virulence evolution in response to vaccination: the case of malaria. Vaccine (2008) 1.40

Plasmodium falciparum infection elicits both variant-specific and cross-reactive antibodies against variant surface antigens. Infect Immun (2003) 1.39

Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites. PLoS Pathog (2012) 1.35

The Plasmodium falciparum STEVOR multigene family mediates antigenic variation of the infected erythrocyte. PLoS Pathog (2009) 1.32

Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. J Clin Invest (2012) 1.31

The frequency of BDCA3-positive dendritic cells is increased in the peripheral circulation of Kenyan children with severe malaria. Infect Immun (2006) 1.28

Recognition of variant Rifin antigens by human antibodies induced during natural Plasmodium falciparum infections. Infect Immun (2002) 1.27

Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles. Sci Transl Med (2012) 1.27

Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigens. Infect Immun (2004) 1.24

The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic area. Mol Cell Proteomics (2011) 1.24

Hierarchical, domain type-specific acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 in Tanzanian children. Infect Immun (2010) 1.19

Modeling the development of acquired clinical immunity to Plasmodium falciparum malaria. Infect Immun (2004) 1.17

Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line. Proc Natl Acad Sci U S A (2002) 1.16

Immunoglobulin G antibody reactivity to a group A Plasmodium falciparum erythrocyte membrane protein 1 and protection from P. falciparum malaria. Infect Immun (2007) 1.13

Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers. PLoS One (2011) 1.08

Malaria transmission and naturally acquired immunity to PfEMP-1. Infect Immun (1999) 1.08

Allelic diversity of the Plasmodium falciparum erythrocyte membrane protein 1 entails variant-specific red cell surface epitopes. PLoS One (2011) 1.07

The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes. Proc Natl Acad Sci U S A (2001) 1.04

DC8 and DC13 var genes associated with severe malaria bind avidly to diverse endothelial cells. PLoS Pathog (2013) 1.03

Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates. Cell Mol Life Sci (2014) 1.03

Young lives lost as B cells falter: what we are learning about antibody responses in malaria. J Immunol (2013) 1.02

Malaria parasite diversity and transmission intensity affect development of parasitological immunity in a mathematical model. Malar J (2012) 1.01

var gene transcription and PfEMP1 expression in the rosetting and cytoadhesive Plasmodium falciparum clone FCR3S1.2. Malar J (2011) 1.01

Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with an erythrocyte membrane protein 1-duffy binding-like 1 alpha domain. Infect Immun (2006) 0.99

Evolution of the multi-domain structures of virulence genes in the human malaria parasite, Plasmodium falciparum. PLoS Comput Biol (2012) 0.97

Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in northeastern Tanzania. Infect Immun (2008) 0.97

A network approach to analyzing highly recombinant malaria parasite genes. PLoS Comput Biol (2013) 0.97

Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks. Infect Immun (2004) 0.97

Population structuring of multi-copy, antigen-encoding genes in Plasmodium falciparum. Elife (2012) 0.95

Immunoglobulin G isotype responses to erythrocyte surface-expressed variant antigens of Plasmodium falciparum predict protection from malaria in African children. Infect Immun (2005) 0.95

Evidence for in vitro and in vivo expression of the conserved VAR3 (type 3) plasmodium falciparum erythrocyte membrane protein 1. Malar J (2012) 0.94

DNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium falciparum variant antigen elicits limited cross-reactive antibody responses. Infect Immun (2003) 0.92

Plasmodium falciparum expressing domain cassette 5 type PfEMP1 (DC5-PfEMP1) bind PECAM1. PLoS One (2013) 0.91

Recombinant Duffy binding-like-alpha domains of Plasmodium falciparum erythrocyte membrane protein 1 elicit antibodies in rats that recognise conserved epitopes. Parasitol Res (2003) 0.90

Evaluation of the acquired immune responses to Plasmodium vivax VIR variant antigens in individuals living in malaria-endemic areas of Brazil. Malar J (2006) 0.90

Insecticide-treated bed nets reduce plasma antibody levels and limit the repertoire of antibodies to Plasmodium falciparum variant surface antigens. Clin Diagn Lab Immunol (2001) 0.90

Inferring malaria parasite population structure from serological networks. Proc Biol Sci (2009) 0.89

Identification of a major rif transcript common to gametocytes and sporozoites of Plasmodium falciparum. Malar J (2010) 0.88

Role of stochastic processes in maintaining discrete strain structure in antigenically diverse pathogen populations. Proc Natl Acad Sci U S A (2011) 0.88

Relationship of binding of immunoglobulin G to Plasmodium falciparum-infected erythrocytes with parasite endemicity and antibody responses to conserved antigen in immune individuals. Clin Diagn Lab Immunol (2004) 0.87

The kinetics of antibody binding to Plasmodium falciparum VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on the membrane knobs. Malar J (2010) 0.86

Plasmodium falciparum var gene expression homogeneity as a marker of the host-parasite relationship under different levels of naturally acquired immunity to malaria. PLoS One (2013) 0.86

Molecular aspects of Plasmodium falciparum Infection during pregnancy. J Biomed Biotechnol (2007) 0.85

A sequence in subdomain 2 of DBL1α of Plasmodium falciparum erythrocyte membrane protein 1 induces strain transcending antibodies. PLoS One (2013) 0.85

Commonly recognised Plasmodium falciparum parasites cause cerebral malaria. Parasitol Res (2003) 0.84

The C-terminal segment of the cysteine-rich interdomain of Plasmodium falciparum erythrocyte membrane protein 1 determines CD36 binding and elicits antibodies that inhibit adhesion of parasite-infected erythrocytes. Infect Immun (2008) 0.84

Cellular immune response to Plasmodium falciparum after pregnancy is related to previous placental infection and parity. Malar J (2002) 0.83

Immune selection and within-host competition can structure the repertoire of variant surface antigens in Plasmodium falciparum--a mathematical model. PLoS One (2010) 0.83

The effects of a partitioned var gene repertoire of Plasmodium falciparum on antigenic diversity and the acquisition of clinical immunity. Malar J (2008) 0.82

CD4+ T cell responses to the Plasmodium falciparum erythrocyte membrane protein 1 in children with mild malaria. J Immunol (2014) 0.82

Global selection of Plasmodium falciparum virulence antigen expression by host antibodies. Sci Rep (2016) 0.82

B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites. Infect Immun (2014) 0.82

Understanding naturally acquired immunity to Plasmodium falciparum malaria. Infect Immun (2003) 0.82

Dissecting the determinants of malaria chronicity: why within-host models struggle to reproduce infection dynamics. J R Soc Interface (2015) 0.82

The humoral response to Plasmodium falciparum VarO rosetting variant and its association with protection against malaria in Beninese children. Malar J (2010) 0.81

T-cell responses to the DBLα-tag, a short semi-conserved region of the Plasmodium falciparum membrane erythrocyte protein 1. PLoS One (2012) 0.81

Characterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers. Infect Immun (2007) 0.80

High plasma levels of soluble intercellular adhesion molecule (ICAM)-1 are associated with cerebral malaria. PLoS One (2013) 0.80

Cloning of the repertoire of individual Plasmodium falciparum var genes using transformation associated recombination (TAR). PLoS One (2011) 0.80

How selection forces dictate the variant surface antigens used by malaria parasites. J R Soc Interface (2011) 0.79

A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies. Cell Mol Life Sci (2016) 0.77

Relationship between Antibody Levels, IgG Binding to Plasmodium falciparum-Infected Erythrocytes, and Disease Outcome in Hospitalized Urban Malaria Patients from Dakar, Sénégal. Biomed Res Int (2016) 0.77

Cytoadhesion to gC1qR through Plasmodium falciparum Erythrocyte Membrane Protein 1 in Severe Malaria. PLoS Pathog (2016) 0.76

In Vitro Variant Surface Antigen Expression in Plasmodium falciparum Parasites from a Semi-Immune Individual Is Not Correlated with Var Gene Transcription. PLoS One (2016) 0.76

Modeling malaria infection and immunity against variant surface antigens in Príncipe Island, West Africa. PLoS One (2014) 0.76

Identification and Characterization of the Antigens Expressed On the Surface of Human Erythrocytes Infected With Plasmodium falciparum. Iran J Parasitol (2013) 0.76

Specificity and cross-reactivity of Plasmodium falciparum variant surface antigen-specific antibody responses. Infect Immun (2003) 0.76

The role of PfEMP1 as targets of naturally acquired immunity to childhood malaria: prospects for a vaccine. Parasitology (2016) 0.76

Serological Conservation of Parasite-Infected Erythrocytes Predicts Plasmodium falciparum Erythrocyte Membrane Protein 1 Gene Expression but Not Severity of Childhood Malaria. Infect Immun (2016) 0.75

Complement receptor 1 and the molecular pathogenesis of malaria. Indian J Hum Genet (2007) 0.75

Plasmodium falciparum parasites causing cerebral malaria share variant surface antigens, but are they specific? Malar J (2010) 0.75

Articles cited by this

Human malaria parasites in continuous culture. Science (1976) 59.70

Indicators of life-threatening malaria in African children. N Engl J Med (1995) 13.17

The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell (1995) 10.35

Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell (1995) 9.31

Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell (1995) 9.31

Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol (1985) 7.14

Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature (1992) 6.42

Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi. Nature (1965) 5.45

Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med (1998) 5.41

An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol (1994) 5.34

Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1996) 3.55

Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science (1986) 3.47

Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science (1998) 3.19

Periodicity and space-time clustering of severe childhood malaria on the coast of Kenya. Trans R Soc Trop Med Hyg (1993) 3.16

Variant antigens and endothelial receptor adhesion in Plasmodium falciparum. Proc Natl Acad Sci U S A (1996) 2.89

Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am J Trop Med Hyg (1991) 2.76

Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. Exp Parasitol (1992) 2.38

A method for freezing and washing red blood cells using a high glycerol concentration. Transfusion (1972) 2.27

Cerebral malaria: the sequestration hypothesis. Parasitol Today (1994) 2.03

Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. Am J Trop Med Hyg (1995) 1.96

Diversity of antigens expressed on the surface of erythrocytes infected with mature Plasmodium falciparum parasites in Papua New Guinea. Am J Trop Med Hyg (1989) 1.94

Low-level Plasmodium falciparum transmission and the incidence of severe malaria infections on the Kenyan coast. Am J Trop Med Hyg (1993) 1.73

Diversity of agglutinating phenotype, cytoadherence, and rosette-forming characteristics of Plasmodium falciparum isolates from Papua New Guinean children. Am J Trop Med Hyg (1994) 1.59

Serological diversity of antigens expressed on the surface of erythrocytes infected with Plasmodium falciparum. Trans R Soc Trop Med Hyg (1994) 1.45

Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions. Am J Trop Med Hyg (1992) 1.41

Plasmodium falciparum: synchronization of asexual development with aphidicolin, a DNA synthesis inhibitor. Exp Parasitol (1984) 1.22

Limited spatial clustering of individual Plasmodium falciparum alleles in field isolates from coastal Kenya. Am J Trop Med Hyg (1997) 1.18

Seasonal variation in agglutination of Plasmodium falciparum-infected erythrocytes. Am J Trop Med Hyg (1998) 1.15

The chromosomal organization of the Plasmodium falciparum var gene family is conserved. Mol Biochem Parasitol (1997) 1.05

Expression of var genes located within polymorphic subtelomeric domains of Plasmodium falciparum chromosomes. Mol Cell Biol (1997) 0.98

Genetic changes in the population of Plasmodium falciparum in a Sudanese village over a three-year period. Am J Trop Med Hyg (1995) 0.97

Small area variation in prevalence of an S-antigen serotype of Plasmodium falciparum in villages of Madang, Papua New Guinea. Am J Trop Med Hyg (1989) 0.96

The effect of mosquito transmission of antigenic variants of Plasmodium chabaudi. Parasitology (1987) 0.92

Articles by these authors

Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet (1997) 13.64

Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ (1999) 12.10

Averting a malaria disaster. Lancet (1999) 9.40

A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol (1985) 7.66

Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg (1987) 6.58

Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature (1992) 6.42

Childhood deaths in Africa: uses and limitations of verbal autopsies. Lancet (1992) 6.14

Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast. Trop Med Int Health (1996) 5.87

Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature (1989) 5.62

Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med (1998) 5.41

Changing home treatment of childhood fevers by training shop keepers in rural Kenya. Trop Med Int Health (1999) 4.43

Admission diagnosis of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical description. QJM (2003) 4.21

Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med (1999) 4.18

The past, present and future of childhood malaria mortality in Africa. Trends Parasitol (2001) 4.10

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet (1999) 3.93

Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg (1997) 3.92

Why do some African children develop severe malaria? Parasitol Today (1991) 3.88

Improving malaria home treatment by training drug retailers in rural Kenya. Trop Med Int Health (2004) 3.65

Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet (2000) 3.64

Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science (1986) 3.47

Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun (1995) 3.20

Understanding of informed consent in a low-income setting: three case studies from the Kenyan Coast. Soc Sci Med (2004) 3.20

Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol (1972) 3.13

Relationships between Plasmodium falciparum transmission by vector populations and the incidence of severe disease at nine sites on the Kenyan coast. Am J Trop Med Hyg (1995) 2.93

A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet (1999) 2.83

Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. Lancet (2001) 2.78

Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg (1999) 2.76

Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet (2000) 2.74

A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature (1988) 2.70

Intracranial pressure in African children with cerebral malaria. Lancet (1991) 2.67

The role of shops in the treatment and prevention of childhood malaria on the coast of Kenya. Trans R Soc Trop Med Hyg (1992) 2.60

Prognostic indicators of early and late death in children admitted to district hospital in Kenya: cohort study. BMJ (2003) 2.56

Trust and informed consent: insights from community members on the Kenyan coast. Soc Sci Med (2005) 2.55

Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology (1987) 2.45

Clinical overlap between malaria and severe pneumonia in Africa children in hospital. Trans R Soc Trop Med Hyg (1997) 2.42

Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. Exp Parasitol (1992) 2.38

A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet (2001) 2.38

Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. Antimicrob Agents Chemother (1990) 2.35

Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age. J Infect Dis (2000) 2.35

The binding site on ICAM-1 for Plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site. Cell (1992) 2.29

Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc Natl Acad Sci U S A (2001) 2.27

Seizures and status epilepticus in childhood cerebral malaria. QJM (1996) 2.22

'Even if they ask you to stand by a tree all day, you will have to do it (laughter)...!': community voices on the notion and practice of informed consent for biomedical research in developing countries. Soc Sci Med (2005) 2.21

Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg (2000) 2.20

Severe P. falciparum malaria in Kenyan children: evidence for hypovolaemia. QJM (2003) 2.18

Cerebral malaria versus bacterial meningitis in children with impaired consciousness. QJM (1999) 2.18

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med (2015) 2.18

A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet (1997) 2.17

The epidemiology of hookworm infection and its contribution to anaemia among pre-school children on the Kenyan coast. Trans R Soc Trop Med Hyg (1999) 2.14

Acidosis in severe childhood malaria. QJM (1997) 2.12

Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Trop Med Int Health (2001) 2.05

Severe anaemia in children living in a malaria endemic area of Kenya. Trop Med Int Health (1997) 2.05

Photographic and angiographic characterization of the retina of Kenyan children with severe malaria. Arch Ophthalmol (1997) 2.04

Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa. Acta Trop (1994) 2.04

A review of the spectrum of clinical ocular fundus findings in P. falciparum malaria in African children with a proposed classification and grading system. Trans R Soc Trop Med Hyg (2000) 2.00

Risk of severe malaria among African infants: direct evidence of clinical protection during early infancy. J Infect Dis (1998) 1.99

An analysis of the geographical distribution of severe malaria in children in Kilifi District, Kenya. Int J Epidemiol (1998) 1.96

The selection landscape of malaria parasites. Science (2010) 1.95

Malaria is an important cause of anaemia in primigravidae: evidence from a district hospital in coastal Kenya. Trans R Soc Trop Med Hyg (1996) 1.90

Hypoglycaemia in African children with severe malaria. Lancet (1987) 1.88

Low-level Plasmodium falciparum transmission and the incidence of severe malaria infections on the Kenyan coast. Am J Trop Med Hyg (1993) 1.73

Paediatric survival and re-admission risks following hospitalization on the Kenyan coast. Trop Med Int Health (2000) 1.73

Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect Immun (2001) 1.72

Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child (1997) 1.71

T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature (1985) 1.69

P2X7-related modulation of pathological nociception in rats. Neuroscience (2007) 1.67

Brain swelling and ischaemia in Kenyans with cerebral malaria. Arch Dis Child (1994) 1.67

Environmental and entomological risk factors for the development of clinical malaria among children on the Kenyan coast. Trans R Soc Trop Med Hyg (1998) 1.67

Naturally acquired immunity to Plasmodium falciparum. Immunol Today (1991) 1.66

Coma scales for children with severe falciparum malaria. Trans R Soc Trop Med Hyg (1997) 1.63

New insights into the epidemiology of malaria relevant for disease control. Br Med Bull (1998) 1.62

Rapid increase in gonorrhoea and syphilis diagnoses in England in 2011. Euro Surveill (2012) 1.62

PfEMP1, polymorphism and pathogenesis. Ann Trop Med Parasitol (1997) 1.56

The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria. Br J Clin Pharmacol (1992) 1.53

Epileptic seizures and malaria in Kenyan children. Trans R Soc Trop Med Hyg (1996) 1.53

TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci (2006) 1.52

The prevalence and morbidity of snake bite and treatment-seeking behaviour among a rural Kenyan population. Ann Trop Med Parasitol (1994) 1.49

Infant parasite rates and immunoglobulin M seroprevalence as a measure of exposure to Plasmodium falciparum during a randomized controlled trial of insecticide-treated bed nets on the Kenyan coast. Am J Trop Med Hyg (1996) 1.49

Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. J Immunol (2000) 1.48

The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. Trans R Soc Trop Med Hyg (1997) 1.46

Further observations on self-catheterization. J Urol (1976) 1.45

Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect Immun (2001) 1.44

Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA. Vaccine (2009) 1.41

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy. Vaccine (2009) 1.41

Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol (2007) 1.41

Deep breathing in children with severe malaria: indicator of metabolic acidosis and poor outcome. Am J Trop Med Hyg (1996) 1.38

Factors influencing admission to hospital during terminal childhood illnesses in Kenya. Int J Epidemiol (1994) 1.38

Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria. Ultrasound Obstet Gynecol (2002) 1.37

Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3. Parasite Immunol (2007) 1.37

Interobserver variation in respiratory signs of severe malaria. Arch Dis Child (1995) 1.36

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial. Lancet (2002) 1.36

Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimens. Am J Trop Med Hyg (1991) 1.35